Search alternatives:
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
4261
-
4262
IL-15 enhanced CD69, CD1d, and CD11a expression of α-GalCer-treated iNKT cells in SLE patients.
Published 2021Subjects: -
4263
-
4264
Defective response to α-GalCer in SLE CD161<sup>+</sup> iNKT cells restored by IL-15.
Published 2021Subjects: -
4265
Deficient α-GalCer-induced expansion of iNKT cells and poor response to IL-15 in SLE patients.
Published 2021Subjects: -
4266
IL-4, but not interferon-γ expression is deficient in iNKT cells from SLE patient.
Published 2021Subjects: -
4267
Dephosphorylation of AMPK by PP2A phosphatase promotes neuritogenic effect of SIM in SH-SY5Y cells.
Published 2013“…Error bar graph shows the difference in neurite length between SIM, SIM + Fostriecin and SIM + AICAR treated cells for 12 hrs (mean ± SEM; N = 50 cells per condition from 3 separate cultures). …”
-
4268
-
4269
-
4270
-
4271
-
4272
-
4273
-
4274
-
4275
-
4276
-
4277
-
4278
Treatment outcomes.
Published 2023“…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”
-
4279
Quality assessment of included papers.
Published 2023“…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”
-
4280
Basic characteristics of the included studies.
Published 2023“…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”